AU Stock MarketDetailed Quotes

EMvision Medical Devices Ltd (EMV)

Watchlist
  • 1.800
  • -0.020-1.10%
20min DelayMarket Closed Jan 16 16:00 AET
167.29MMarket Cap-15.65P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EMvision Medical Devices Ltd (EMV) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense
3.11%13.9M
23.32%13.48M
4.40%10.93M
2.77%10.47M
99.17%10.18M
16.93%5.11M
4.37M
Selling and administrative expenses
13.15%8.9M
-3.73%7.86M
10.11%8.17M
6.14%7.42M
265.58%6.99M
-9.97%1.91M
--2.12M
-Selling and marketing expense
----
----
----
----
----
----
--131.67K
-General and administrative expense
13.15%8.9M
-3.73%7.86M
10.11%8.17M
6.14%7.42M
265.58%6.99M
-4.02%1.91M
--1.99M
Research and development costs
-14.09%4.04M
133.49%4.7M
-13.49%2.01M
-14.12%2.33M
-7.76%2.71M
49.73%2.94M
--1.96M
Depreciation amortization depletion
-0.51%408.49K
20.05%410.58K
40.55%342.01K
113.53%243.34K
--113.96K
----
----
-Depreciation and amortization
-0.51%408.49K
20.05%410.58K
40.55%342.01K
113.53%243.34K
--113.96K
----
----
Other operating expenses
9.71%553.3K
24.54%504.34K
-15.47%404.95K
28.47%479.08K
40.11%372.9K
-7.87%266.15K
--288.89K
Operating profit
-3.11%-13.9M
-23.32%-13.48M
-4.40%-10.93M
-2.77%-10.47M
-99.17%-10.18M
-16.93%-5.11M
-4.37M
Net non-operating interest income (expenses)
116.48%488.14K
167.48%225.49K
3,497.86%84.3K
-106.71%-2.48K
1.66%36.96K
4,877.53%36.36K
-761
Non-operating interest income
69.02%576.71K
185.34%341.21K
664.52%119.58K
-66.58%15.64K
26.64%46.8K
--36.95K
----
Non-operating interest expense
-23.46%88.57K
228.03%115.72K
94.66%35.28K
84.22%18.12K
1,547.74%9.84K
-21.55%597
--761
Other net income (expenses)
-54.97%5.05M
60.89%11.22M
59.92%6.97M
149.32%4.36M
9.20%1.75M
13.22%1.6M
1.41M
Other non-operating income (expenses)
-54.97%5.05M
60.89%11.22M
59.92%6.97M
149.32%4.36M
9.20%1.75M
13.22%1.6M
--1.41M
Income before tax
-311.22%-8.36M
47.51%-2.03M
36.64%-3.87M
27.26%-6.11M
-141.64%-8.4M
-17.45%-3.48M
-2.96M
Income tax
107.83%1.45M
697.74K
0
0
0
0
0
Earnings from equity interest net of tax
Net income
-259.23%-9.81M
29.48%-2.73M
36.64%-3.87M
27.26%-6.11M
-141.64%-8.4M
-17.45%-3.48M
-2.96M
Net income continuous operations
-259.23%-9.81M
29.48%-2.73M
36.64%-3.87M
27.26%-6.11M
-141.64%-8.4M
-17.45%-3.48M
---2.96M
Noncontrolling interests
Net income attributable to the company
-259.23%-9.81M
29.48%-2.73M
36.64%-3.87M
27.26%-6.11M
-141.64%-8.4M
-17.45%-3.48M
-2.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-259.23%-9.81M
29.48%-2.73M
36.64%-3.87M
27.26%-6.11M
-141.64%-8.4M
-17.45%-3.48M
-2.96M
Diluted earnings per share
-238.64%-0.1148
31.93%-0.0339
38.67%-0.0498
32.22%-0.0812
-113.93%-0.1198
11.11%-0.056
-0.063
Basic earnings per share
-238.64%-0.1148
31.93%-0.0339
38.67%-0.0498
32.22%-0.0812
-113.93%-0.1198
11.11%-0.056
-0.063
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020(FY)Jun 30, 2019
Total revenue
Cost of revenue
Gross profit
Operating expense 3.11%13.9M23.32%13.48M4.40%10.93M2.77%10.47M99.17%10.18M16.93%5.11M4.37M
Selling and administrative expenses 13.15%8.9M-3.73%7.86M10.11%8.17M6.14%7.42M265.58%6.99M-9.97%1.91M--2.12M
-Selling and marketing expense --------------------------131.67K
-General and administrative expense 13.15%8.9M-3.73%7.86M10.11%8.17M6.14%7.42M265.58%6.99M-4.02%1.91M--1.99M
Research and development costs -14.09%4.04M133.49%4.7M-13.49%2.01M-14.12%2.33M-7.76%2.71M49.73%2.94M--1.96M
Depreciation amortization depletion -0.51%408.49K20.05%410.58K40.55%342.01K113.53%243.34K--113.96K--------
-Depreciation and amortization -0.51%408.49K20.05%410.58K40.55%342.01K113.53%243.34K--113.96K--------
Other operating expenses 9.71%553.3K24.54%504.34K-15.47%404.95K28.47%479.08K40.11%372.9K-7.87%266.15K--288.89K
Operating profit -3.11%-13.9M-23.32%-13.48M-4.40%-10.93M-2.77%-10.47M-99.17%-10.18M-16.93%-5.11M-4.37M
Net non-operating interest income (expenses) 116.48%488.14K167.48%225.49K3,497.86%84.3K-106.71%-2.48K1.66%36.96K4,877.53%36.36K-761
Non-operating interest income 69.02%576.71K185.34%341.21K664.52%119.58K-66.58%15.64K26.64%46.8K--36.95K----
Non-operating interest expense -23.46%88.57K228.03%115.72K94.66%35.28K84.22%18.12K1,547.74%9.84K-21.55%597--761
Other net income (expenses) -54.97%5.05M60.89%11.22M59.92%6.97M149.32%4.36M9.20%1.75M13.22%1.6M1.41M
Other non-operating income (expenses) -54.97%5.05M60.89%11.22M59.92%6.97M149.32%4.36M9.20%1.75M13.22%1.6M--1.41M
Income before tax -311.22%-8.36M47.51%-2.03M36.64%-3.87M27.26%-6.11M-141.64%-8.4M-17.45%-3.48M-2.96M
Income tax 107.83%1.45M697.74K00000
Earnings from equity interest net of tax
Net income -259.23%-9.81M29.48%-2.73M36.64%-3.87M27.26%-6.11M-141.64%-8.4M-17.45%-3.48M-2.96M
Net income continuous operations -259.23%-9.81M29.48%-2.73M36.64%-3.87M27.26%-6.11M-141.64%-8.4M-17.45%-3.48M---2.96M
Noncontrolling interests
Net income attributable to the company -259.23%-9.81M29.48%-2.73M36.64%-3.87M27.26%-6.11M-141.64%-8.4M-17.45%-3.48M-2.96M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -259.23%-9.81M29.48%-2.73M36.64%-3.87M27.26%-6.11M-141.64%-8.4M-17.45%-3.48M-2.96M
Diluted earnings per share -238.64%-0.114831.93%-0.033938.67%-0.049832.22%-0.0812-113.93%-0.119811.11%-0.056-0.063
Basic earnings per share -238.64%-0.114831.93%-0.033938.67%-0.049832.22%-0.0812-113.93%-0.119811.11%-0.056-0.063
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -